Can embryonic stem cell therapy diabetes help?

Because type 1 diabetes occurs as a result of a single cell type loss – the beta cells, located in the pancreatic islets – and due to the proven fact that some amount of islet cells are able to restore production of insulin, the illness can be treated with regenerative diabetes stem cell treatment. For patients suffering from diabetes, embryonic stem cells have huge potential. They are able to grow into any cells from over 200 cell types and discover the cells that can be turned insulin-producing beta cells thus making type1 diabetes cell therapy effective, because the secretion of insulin will be restored this way. Many researchers work over the problem at present. Type 1 diabetes cell therapy can give so much. It simply changes the life of the person with diabetes. Embryonic stem cells are investigated in the best laboratories of the world.

Why choose diabetes embryonic stem cell therapy?

Theoretically, embryonic stem cells have advantages over transplant therapies that are present currently: there is no problem with search for donor when diabetes stem cell treatment is practiced. They can create an limitless source of fresh beta cells. Such attributes made people look for the best type of stem cells. Type 1 diabetes stem cell needs just some sign that will launch the promotion into beta cells. It can occur right in the laboratory prior to transplantation. In this way diabetes stem cell therapy will begin before the administration. How to make type 1 diabetes stem cells therapy successful? It should meet the requirements of transplant therapy.

Different types of cells are studied to determine the right diabetes stem cells treatment. For patients suffering from diabetes, embryonic stem cells administration can provide a perfect relief.

Potential development of type1 diabetes stem cell therapy

Type1 diabetes stem cell therapy can be, probably, based on transplantation of next stem cells:

  • embryonic;
  • induced pluripotent;
  • spermatogonial;
  • adult.

Embryonic stem cells

 Being pluripotent embryonic stem cells can turn into any cell type in the body. However, the task is challenging for treatment of diabetes. Stem cell that were formed anew are separated with difficulty from the ones that are not differentiated. Therefore their future is not clear and diabetes cell treatment will not produce good result.

Induced pluripotent stem cells – these are the cells that are taken from adult cells and reprogrammed. First results of diabetes stem cell therapy with application of this principle appeared in 2010. The potential danger is the risk of tumor. Much must be done to introduce the technique.

Spermatogonial and adult stem cells are other types of cell that can be involved to provide diabetes stem cell treatment.